The trademark application SCTbio was filed by SCT Cell Manufacturing s.r.o., a corporation established under the laws of the Czech Republic (the "Applicant"). The application was published for oppositions on October 11, 2021, and it was registered by office on January 18, 2022 without any oppositions.
It was designated 'Basic Application' for International Application 1654220 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).
Change of name and address of the trademark registration was recorded on February 8, 2022. Change of name and professional address of the trademark registration was recorded on October 17, 2022. A transfer of the trademark registration was recorded on November 15, 2022.
Goods And Services
The mark was filed in class 39 with Labeling, relabeling, storage and distribution of cell therapy materials.
The mark was filed in class 40 with following description of goods:
Manufacture of cell therapy materials to the order and specification of others including filling
Manufacture of viral and non-viral vectors to the order and specification of others
Manufacture of cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies to the order and specification of others.
The mark was filed in class 42 with following description of goods:
Pharmaceutical research and development, namely for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies
Scientific research and development, namely for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies
Consultation in the field of pharmaceutical research and development, namely for cell therapy material materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies
Product research and development, namely for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies
Biological materials testing services and biological laboratory services, namely for cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies
Contract research services in the field of cell therapy materials, cellular vaccines, CAR-T therapies, TCR-T therapies, or CAR-NK therapies.